Pfizer on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the ...

Obesity is a growing global health concern, with projections indicating that more than half of the world’s population will be ...

Minnesota lawmakers are once again calling on insurance companies to cover anti-obesity medications like Ozempic and Wegovy ...

The obesity medicine field has gained a new entrant, with AbbVie licensing an experimental drug from a Danish company.

A licensing deal with Denmark’s Gubra gives the immunology giant control of an experimental therapy that could compete with ...

Obesity has long been classified as a global epidemic — and new data published in The Lancet journal spotlights how much worse it could get. A team of researchers found that in 2021, one billion men ...

Opens in a new tab or window The rise in the global incidence of obesity has been exponential, while treatment advances have not kept pace with this chronic disease. Limited options are ...

A team of researchers have made a groundbreaking development related to a protein that is naturally produced in the body but ...

Patients who have significant weight loss with anti-obesity medications after joint replacement show reductions in the risk for revision; however, caution on their use is urged as patients recover.

Many Marylanders struggle with obesity but cannot get access to weight loss medications because insurance will not pay for ...